Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-005 - The Clinical Significance of Serum BAP, TRACP 5b and ICTP as Bone Metabolic Markers for Bone Metastasis Screening in Lung Cancer Patients
09:30 - 09:30 | Author(s): C. Tang
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-038 - The significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK target therapy
09:30 - 09:30 | Author(s): N. Zhang
- Abstract
Loading...
-
+
P1.17 - Poster Session 1 - Bronchoscopy, Endoscopy
- Type: Poster Session
- Track: Pulmonology + Endoscopy/Pulmonary
- Presentations: 10
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.17-001 - Transumbilical versus conventional thoracoscopic lung wedge resection: safety and efficacy in a canine survival model
09:30 - 09:30 | Author(s): Y. Liu
- Abstract
Loading...
-
+
P1.22 - Poster Session 1 - Epidemiology, Etiology
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 12
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.22-005 - A Prospective, Molecular Epidemiological Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer with Adenocarcinoma Histology (PIONEER study) - China Subset Analysis
09:30 - 09:30 | Author(s): Y. Shi
- Abstract
Loading...
-
+
O04 - Molecular Pathology I
- Type: Oral Abstract Session
- Track: Pathology
- Presentations: 8
- Moderators:I.I. Wistuba
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom A, Level 1
-
+
O04.07 - Distinguish synchronous multiple primary lung cancers from intrapulmonary metastasis by genome sequencing
11:35 - 11:45 | Author(s): Y. Liu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session 2 - Cancer Biology
- Type: Poster Session
- Track: Biology
- Presentations: 26
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.01-006 - Novel small compounds targeting cancer stem cells of non-small cell lung cancer
09:30 - 09:30 | Author(s): C. Yang
- Abstract
Loading...
-
+
P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.05-002 - Resistance to BH3 mimetic S1 in SCLC cells that up-regulate and phosphorylate Bcl-2 through ERK1/2
09:30 - 09:30 | Author(s): Y. Liu
- Abstract
Loading...
-
+
P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 50
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.06-040 - Circulating cytokines and angiogenic factors (CAFs) as markers of clinical response in a randomized phase II study of trametinib vs docetaxel for patients with KRAS-mutant non-small cell lung cancer (NSCLC) (MEK114653, NCT01362296)
09:30 - 09:30 | Author(s): H.T. Tran
- Abstract
Loading...
-
+
P2.11 - Poster Session 2 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 46
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.11-002 - A Prospective, Open-labeled, Randomized, Multicenter Phase II Study to Evaluate Efficacy and Safety of Erlotinib vs NP Chemotherapy as Adjuvant Therapy in Post Radical Operation stage IIIA NSCLC Patients With EGFR 19 or 21 Exon Mutation (EVAN, ML28280, NCT01683175)
09:30 - 09:30 | Author(s): D. Yue
- Abstract
Loading... -
+
P2.11-043 - Analysis of clinicopathological features for Chinese patients with advanced non-small cell lung cancer harboring EML4-ALK fusion genes
09:30 - 09:30 | Author(s): Y. Shi
- Abstract
Loading...
-
+
MO12 - Prognostic and Predictive Biomarkers III
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 12
- Moderators:B. Han
- Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
-
+
MO12.03 - Biomarker analysis of a randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gmcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer
10:40 - 10:45 | Author(s): L. Zhang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
